Remove Communication Remove Diabetes Remove Immunity
article thumbnail

Provention’s Tzield can delay type 1 diabetes. But will it reach all patients?

Pharmaceutical Technology

On November 17, 2022, the FDA approved Provention Bio’s Tzield (teplizumab) , making it the first and only treatment to delay the onset of type 1 diabetes (T1D). Tzield’s approval brings the opportunity to explore how the drug can advance diabetes education, treatment, and management. “We Equity in early-stage testing.

article thumbnail

Novo Nordisk and Aspect join forces for bioprinting tissue therapeutics

Pharmaceutical Technology

The Canadian biotech Aspect Biosystems has announced a partnership with Novo Nordisk to produce bioprinted tissue therapeutics for diabetes. On April 12, the Dutch pharmaceutical giant Novo Nordisk announced a partnership to grow its diabetes portfolio. The company is developing therapeutic platforms for the liver and the pancreas.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Recap of the NHC’s Annual Membership Meeting and Luncheon & New Board Announced

Putting Patients First Blog

Recap of the NHC’s Annual Membership Meeting and Luncheon & New Board Announced December 18, 2023 By: Bhriana Onuoha, Senior Coordinator, Communications On Dec. 12, 2023, the National Health Council (NHC) hosted its 103 rd Annual Membership Meeting and Luncheon.

article thumbnail

A Look at the OBGYN Qualifying Exam Blueprint

Board Vitals - Pharmacist

It evaluates knowledge on preconception and prenatal care, including genetics and management of pregnancy-related diseases like diabetes and cardiovascular conditions. It assesses routine care including preventative screenings, immunizations, and genetic and cancer risk assessments.

article thumbnail

Why does Pycnogenol® offer such a wide range of health benefits?

Express Pharma

In a 3-month study on diabetic retinopathy, Pycnogenol ® supplementation improved the retinal blood flow by around 30% compared to no change in the control patients (7). Initially, inflammation is a complex protective response of the body to harmful stimuli and is part of innate immunity. References 1. Rohdewald P, Passwater RA.

Diabetes 104
article thumbnail

New Video Series: Are You at Higher Risk for COVID-19?

Putting Patients First Blog

August 28, 2023 By: Jennifer Schleman, Senior Vice President, Communications & Governance Today, the National Health Council (NHC) announced a new digital video series that features discussions with prominent health care experts and advocates about the importance of measuring and reducing personal risk associated with COVID-19.

article thumbnail

Muscle Wasting and Hashimoto’s

The Thyroid Pharmacist

Other causes of myopathies include immune disorders that cause inflammation and pain. These signals create communication and function within nerves and muscles, as the electrolytes move in or out of cells. Research has shown glutamine to be effective in restoring insulin response in diabetics. [23]